1 year results
Anchorperson | Patrick Serruys (Ireland)
Spokesperson | Andreas Baumbach (United kingdom)
Discussant | Giuseppe Tarantini (Italy), Julia Mascherbauer (Austria), Francesco Bedogni (Italy), Andreas Ruck (Sweden), Markus Kasel (Switzerland), Fausto Feres (Brazil)
| Time | Topic | Speaker |
|---|---|---|
| 12:30 | Session Objectives | Patrick Serruys (Ireland) |
| 12:31 | First ever analysis of TAVR trial based on VARC-3 | Deep understanding of the basic principle of analysis | Yoshinobu Onuma (Ireland) |
| 12:41 | One-year outcomes of Landmark Trial | Patrick Serruys (Ireland) |
| 12:51 | Discussion | All |
| 12:57 | Detailed analysis of composite primary endpoints (Clinical Efficacy + QOL) | Andreas Baumbach (UK) |
| 13:07 | Hemodynamic analysis | Matjaz Bunc (Slovenia) |
| 13:17 | Predictors of post-TAVI conduction system disturbances resulting in new PPI with and self-expanding THV systems | Core lab analysis | Pieter Smits (The Netherlands) |
| 13:27 | Discussion | All |
| 13:33 | 1 year outcomes from the Landmark Trial | Women Cohort | Ignacio Amat Santos (Spain) |
| 13:43 | 1 year outcomes from the Landmark Trial | Small Annuli patients | Niels Van Royen (The Netherlands) |
| 13:53 | Discussion | All |
| 13:59 | Session evaluation and key learnings | Axel Linke (Germany) |
